Inogen | INGN - Current Assets


Inogen reported $203.72M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Accuray USD 303.6M 13.86M Sep/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Artivion USD 358.08M 20.58M Dec/2025
AtriCure USD 322.52M 21.41M Dec/2025
Baxter International USD 6.85B 25M Mar/2026
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Boston Scientific USD 8.68B 110M Mar/2026
Chart Industries USD 2.9B 40.5M Dec/2025
Cooper Companies USD 2.13B 27.4M Dec/2025
Dexcom USD 4.33B 298.4M Mar/2026
Edwards Lifesciences USD 6.74B 380M Dec/2025
Globus Medical USD 2.13B 201.25M Dec/2025
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.91B 54.6M Dec/2025
Masimo USD 926M 122.3M Dec/2025
Medtronic USD 24.07B 75M Dec/2025
Orthofix International USD 461.52M 44.67M Mar/2026
Philips EUR 9.93B 654M Dec/2025
ResMed USD 4.06B 245.26M Mar/2026
Steris USD 2.29B 179.9M Dec/2025
Stryker USD 13.34B 1.42B Mar/2026
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.94B 47.65M Dec/2025
X T L Biopharmaceuticals USD 533K 807K Jun/2025
Zimmer Biomet Holdings USD 4.96B 157.4M Mar/2026